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Objective: To investigate the correlation between quantitative dynamic contrast enhanced magnetic resonance imaging 
(DCE-MRI) parameters and microvascular density (MVD) in a human-colon-cancer xenograft mouse model using 3 Tesla MRI. 
Materials and Methods: A human-colon-cancer xenograft model was produced by subcutaneously inoculating 1 x 10
6 DLD-
1 human-colon-cancer cells into the right hind limbs of 10 mice. The tumors were allowed to grow for two weeks and then 
assessed using MRI. DCE-MRI was performed by tail vein injection of 0.3 mmol/kg of gadolinium. A region of interest (ROI) 
was drawn at the midpoints along the z-axes of the tumors, and a Tofts model analysis was performed. The quantitative 
parameters (K
trans, Kep and Ve) from the whole transverse ROI and the hotspot ROI of the tumor were calculated. 
Immunohistochemical microvessel staining was performed and analyzed according to Weidner’s criteria at the corresponding 
MRI sections. Additional Hematoxylin and Eosin staining was performed to evaluate tumor necrosis. The Mann-Whitney test 
and Spearman’s rho correlation analysis were performed to prove the existence of a correlation between the quantitative 
parameters, necrosis, and MVD.
Results: Whole transverse ROI of the tumor showed no significant relationship between the MVD values and quantitative 
DCE-MRI parameters. In the hotspot ROI, there was a difference in MVD between low and high group of K
trans and Kep that 
had marginally statistical significance (ps = 0.06 and 0.07, respectively). Also, K
trans and Kep were found to have an inverse 
relationship with MVD (r = -0.61, p = 0.06 in K
trans; r = -0.60, p = 0.07 in Kep).
Conclusion: Quantitative analysis of T1-weighted DCE-MRI using hotspot ROI may provide a better histologic match than 
whole transverse section ROI. Within the hotspots, K
trans and Kep tend to have a reverse correlation with MVD in this colon 
cancer mouse model.
Index terms: Colorectal cancer; MVD; Nude mouse model; Magnetic resonance imaging; Permeability; Angiogenesis; T1 dynamic 
contrast enhanced imaging; K
trans; DLD-1
Received March 24, 2011; accepted after revision July 12, 2011.
This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health Welfare, Republic of Korea 
(A070001), and by the faculty research grant of Yonsei University College of Medicine (6-2008-0104), and by the KRIBB Research 
Initiative Program (KGS1211012). We would also like to acknowledge Siemens Healthcare Korea for technical support as part of a 
cooperative research and development agreement.
Corresponding author: Ho-Taek Song, MD, Department of Radiology, College of Medicine, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, 
Seoul 120-752, Korea. 
• Tel: (822) 2228-2370 • Fax: (822) 393-3035 • E-mail: hotsong@yuhs.ac
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.  
Original Article
http://dx.doi.org/10.3348/kjr.2011.12.6.722
pISSN 1229-6929 · eISSN 2005-8330
Korean J Radiol 2011;12(6):722-730Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 723
3T DCE-MRI Quantitative Parameters and MVD in Human-Colorectal-Cancer Mouse Model
INTRODUCTION
Angiogenesis involves the formation of new capillaries 
from existing blood vessels and is an essential component 
of normal physiological as well as pathological processes. 
Tumors require angiogenesis for growth and tumor 
progression (1, 2). Methods for assessing the status 
of angiogenesis are valuable when evaluating cancer 
response to therapy. Microvessel density (MVD) has been 
used to evaluate the angiogenic activity of tumors (3). 
However, it does not reflect the functional status of the 
tumor vasculature, and invasive methods are necessary for 
obtaining specimens.
Permeability of a tumor vessel also reflects the angiogenic 
activity of the tumor (4, 5). T1 weighted dynamic contrast 
enhanced magnetic resonance imaging (DCE-MRI) has 
been proposed as a non-invasive method of assessing the 
permeability of the tumor vessel (6-9). Transendothelial 
permeability, capillary surface area, and lesion leakage 
space can be measured using quantitative parameters based 
on the two-compartment Tofts model on the condition 
that the exchange of contrast agent occurs only between 
the intravascular space and the tumor interstitial space 
(6). K
trans stands for the volume transfer constant of the 
contrast agent, determining the rate at which the contrast 
media passes from the intravascular space into the tumor 
interstitial space. The back diffusion of contrast agent from 
the interstitial space of the tumor into the intravascular 
space is determined by the rate constant Kep. Ve represents 
the extravascular-extracellular leakage space. Because of 
the variability of derived quantitative parameters from T1-
weighted DCE-MRI according to tissue characteristics and 
cancer type (7-9), correlating quantitative parameters with 
MVD would help to interpret the validity and meaning of the 
measured parameters. Reduction of microvessel blood flow 
after radiation therapy in locally advanced rectal cancer 
patients was correlated with decreased endothelial transfer 
coefficient value and MVD, as reported by de Lussanet et 
al. (10). Tuncbilek et al. (11) reported that the parameters 
from the time-intensity curves of DCE-MRI was correlated 
with postoperative MVD, histologic grade, and presence 
of metastasis. Zhang et al. (12) reported that the time 
to peak was negatively correlated with MVD and vascular 
endothelial growth factor (VEFG) in rectal cancer. Ceelen 
et al. (13) reported that radiation therapy reduces tumor 
vascular leakage and enhances tissue oxygenation, which 
was correlated with reduced K
trans and Ve of DEC-MRI and not 
correlated with MVD or VEGF expression in the colorectal 
tumor rat model.
In this study, we investigated the correlation between 
the quantitative DCE-MRI parameters and MVD in human-
colon-cancer xenograft mouse models of various sizes using 
a clinical 3 Tesla (T) scanner.
MATERIALS AND METHODS
Experimental Model
The study protocol was approved by the local ethics 
committee for animal care and use. Experiments were 
performed in 10 adult (5-week-old) (SLC, Kotoh-cho, Japan) 
female nude mice, each weighing 17-20g. A human DLD-
1 colon cancer cell suspension (1 x 10
6 cells in 100 µL 
phosphate buffered saline) was injected subcutaneously 
into the right hind limbs of the mice. Tumors were allowed 
to grow for approximately 7 to 14 days, until reaching a 
predetermined size, the longest diameter of which ranged 
from 0.6 cm to 2 cm.
Dynamic Contrast Enhanced MRI
All MRI studies were performed using a 3T MR scanner 
(MAGNETOM Tim Trio, Siemens Healthcare, Erlangen, 
Germany) with a four-phased array wrist coil. Mice were 
placed prone in a plastic holder for ease of fixation and 
injection of contrast agent, and an inhaled anesthesia was 
used to avoid movement during imaging. Anesthesia was 
maintained with 2% isoflurane in a mixture of 100% 1 L/
min oxygen. The tail vein was cannulated for intravenous 
injection of gadolinium contrast agent.
All images were obtained in the transverse plane using 
the following sequences: transverse T2-weighted turbo 
spin-echo (TSE) sequence (repetition time [TR] msec/echo 
time [TE] msec) 4930/128, echo train length of 25, one 
signal acquired, matrix of 114 x 192) applied with a section 
thickness of 1.0 mm, an intersection gap of 1.1 mm, and 
a flip angle of 160°. The field of view was 35 x 60 mm
2, 
which included the tumor in its entirety (20 sections) with 
a resultant voxel size of 0.3 x 0.3 x 1.0 mm
3. 
Dynamic contrast-enhanced MR imaging included two 
precontrast T1-weighted measurements (3D VIBE, TR/TE 
8.3/2.3, 20 axial slices [slice thickness, 1.04 mm], field 
of view 50 x 50 mm, matrix 90 x 128) with different flip 
angles (2°, 15°) to determine the T1 relaxation time in 
the blood and tissue before the arrival of contrast agent on 
a pixel-by-pixel basis. This was followed by T1-measured Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 724
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dynamic contrast-enhanced series using a TWIST sequence 
(TR/TE 5.8/2.4, flip angle of 12°, and all other parameters 
the same as for the precontrast image).
Sixty dynamic measurements were performed on the 
entire volume of 20 sections. The acquisition time was 6.2 
seconds with a single dynamic measurement. After the first 
five measurements, an intravenous bolus of gadopentetate 
dimeglumine (Magnevist; Schering, Erlangen, Germany) 
at a concentration of 0.05 mmol/mL was administered by 
manual injection at a dose of 0.3 mmol/kg over a maximum 
period of five seconds. The results of a previous pilot study 
showed that this dose of contrast agent provides maximal 
signal enhancement with the same sequence used in this 
study (data not shown).
The scanned data were transferred onto an image 
processing workstation (Leonardo, Siemens Healthcare, 
Erlangen, Germany) and analyzed using Tissue4D® software 
(Siemens Healthcare, Erlangen, Germany). A value for the 
arterial input function was automatically calculated by 
the software without an arterial region of interest (ROI) 
measurement procedure. To verify the applicability of the 
programmed arterial input function, the enhancement 
pattern of the normal thigh muscles opposite to the 
tumor was also analyzed. All mice showed similar patterns 
of enhancement in muscle ROI, with minimal variation 
between animals.
Tumor ROI was drawn at the midpoint along the z-axis 
of the mass by a third-year resident under the supervision 
of a senior radiologist. Two ROIs were drawn and measured 
for each mouse. ROI 1 covered the whole transection area 
of the tumor. ROI 2 covered only the hotspot area in the 
tumor. Hotspots in the MR images were selected to be 
matched with a hotspot in immunohistochemical staining. 
Dynamic data from ROIs 1 and 2 were fitted pixel by pixel 
to a pharmacokinetic model described by Tofts et al. (6), of 
which the quantitative parameters K
trans, Kep, and Ve, were 
calculated.
Histopathological Analysis
After DCE-MRI is performed, the tumor was dissected from 
the surrounding tissue under ether anesthesia and sterile 
conditions. The mice were euthanized at the end of the 
surgical procedure in a CO2 chamber. The dissected tumor 
was fixed with 10% formaldehyde solution and preserved at 
4°C for 24 hours. Then, 6 μm thick slide sections were made 
to correspond with the MR images. Immunohistochemical 
staining was also performed as follows: Deparaffinized 
slide sections were incubated with an anti-CD31 primary 
monoclonal antibody (Abcam, Cambridge, MA) followed 
by incubation with a biotinylated secondary antibody. The 
sections were then incubated with avidin-biotinylated 
peroxidase complex reagent and binding reactions were 
visualized using 3,3-diaminobenzidine (DAB). The stained 
microvessels were heterogeneous and the areas of highest 
neovascularization were mostly found at the periphery of 
the tumor. When scanned in a low-power field (100 x), 
highly vascularized areas were considered to be hotspots. 
Three hotspots were examined respectively and vessels 
were manually counted in a high-power field (200 x) with 
ocular grids. The grading and counting method described by 
Weidner et al. (14) was adapted for evaluation of MVD. Any 
brown-stained endothelial cell or endothelial cell cluster 
that was clearly separate from the adjacent microvessels, 
tumor cells, and other connective tissue elements was 
considered as a single countable microvessel. The sum of 
counts per field (total area = 0.578 mm
2) represented a 
single hotspot. The highest vessel count among the three 
hotspots was used as the MVD. Hematoxylin and Eosin 
staining was performed in a consecutive slide to confirm 
to tumor necrosis. The area including the hot spots was 
scanned with low-power fields (2 x, 40 x). The outer tumor 
border and tumor necrosis was manually circumscribed 
by using Image J software (NIH, Bethesda, MD). Then, 
the total pixel area of the tumor and necrotic region was 
automatically calculated. Histological necrotic fraction (NF) 
was defined as the division of total pixel area of necrosis by 
the total pixel area within the tumor border.
Statistical Analysis
The mice were divided into two subgroups according 
to their K
trans, Kep, and Ve values. If a parameter was less 
than the median value, the mouse was assigned to the 
“low” group. And, if a parameter was above the median 
value, then the mouse was assigned to the “high” group. 
The Mann-Whitney test was performed to validate the 
differences in MVD between the low and high groups 
according to each parameter. The relationship between 
MVD, perfusion parameters and necrotic fraction of the 
tumor was examined by Spearman’s correlation analysis. The 
correlation coefficient (τ) expresses the degree of change 
in the two corresponding variables. A coefficient closer to 
1 indicates a positive correlation and a coefficient closer to 
-1 indicates a negative correlation. Statistical significance 
was accepted with a p value of less than 0.05. Statistical Korean J Radiol 12(6), Nov/Dec 2011 kjronline.org 725
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analyses were performed using computer software (PASW 
Statistics 18; SPSS Inc., Chicago, IL). 
RESULTS
Tumor size, DCE-MRI derived parameters, and MVD of 10 
nude mice are summarized in Table 1. The range in tumor 
Table 1. Summary of Quantitative T1-Weighted Dynamic Contrast Enhanced MRI Parameters, Size and Microvascular 
Density
No.
(#)
Size
(mm)
Whole Transverse Section (ROI 1) Hotspots (ROI 2) MVD
(1/0.578 mm
2)
NF
K
trans (Sec
-1) Kep (Sec
-1) Ve K
trans (Sec
-1) Kep (Sec
-1) Ve
1 6.9 0.118 3.054 0.091 0.173 3.631 0.085 71 0.29
2 7.4 0.285 6.341 0.063 0.429 9.675 0.05 53 0.03
3 8.1 0.098 2.105 0.12 0.301 8.039 0.041 59 0.22
4 9.2 0.112 2.727 0.078 0.301 6.486 0.077 58 0.14
5 10 0.141 3.552 0.079 0.299 6.32 0.061 64 0.36
6 10.2 0.168 3.739 0.051 0.269 5.624 0.065 69 0.02
7 12.1 0.188 4.463 0.07 0.293 6.864 0.044 69 0.11
8 12.7 0.147 3.412 0.09 0.278 6.133 0.083 119 0.05
9 16.1 0.072 3.398 0.072 0.334 6.888 0.093 78 0.04
10 16.4 0.113 3.042 0.054 0.237 5.393 0.053 108 0.31
Note.— MVD = microvascular density, NF = necrotic fraction: total pixel areas included in necrotic regions/total pixel areas 
included within tumor border
Table 2. Difference in Microvascular Density between Low and High Groups of Each Dynamic Contrast Enhanced MRI 
Parameter
Whole Transverse Section (ROI 1) Hotspots (ROI 2)
MVD
P Value
MVD
P Value
Low High Low High
K
trans 71 69 0.84 71 59 0.06
Kep 71 69 0.84 89.5 61.5 0.07
Ve 69 64 0.84 64 71 0.22
Note.— MVD = microvascular density, Low = group of mice with dynamic contrast enhanced MRI parameter values below median 
value, High = group of mice with dynamic contrast enhanced MRI parameter values above median value, MVD values are median. 
P value < 0.05 is considered to be statistically significant.
Fig. 1. Box whisker plot of microvascular density evaluating region of interest drawn on hotspots. 
Distribution of low and high groups is shown in K
trans (A) and Kep (B).
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size was 7.4 to 16.4 mm (average, 10.9 ± 3.3 mm). Table 2 
describes the difference in the MVD value between the low 
and high value groups at each DCE-MRI parameter. In the 
case of the whole transverse ROI, there was no difference in 
MVD values between the low and high groups. However, in 
the case of hotspots, the median value of K
trans and Kep in the 
low group was higher than that of the high group. Although 
these differences did not reach statistical significance (p = 
0.06 in K
trans, p = 0.07 in Kep), a box and whisker plot clearly 
showed the separated distribution of MVD of the two groups 
Table 3. Relationship between Perfusion Parameters, Microvascular Density, and Tumor Necrotic Fraction
ROI 1
MVD NF
ROI 2
MVD NF
τ p τ p τ p τ p
K
trans -0.170 0.61 -0.370 0.27 K
trans -0.610 0.06* -0.340 0.31
Kep -0.109 0.74 -0.515 0.12 Kep -0.602 0.07* -0.358 0.28
Ve -0.012 0.97 0.455 0.17 Ve 0.492 0.14 -0.139 0.68
Note.— Correlation coefficient (τ) represents degree of change in two corresponding variables. P value < 0.05 is considered to be 
statistically significant. *Represents borderline statistical significance. MVD = microvascular density, NF = necrotic fraction, ROI 1 
= whole transverse section, ROI 2 = hotspots
Fig. 2. Representative scatter diagrams showing relationships between microvascular density, necrotic fraction, and dynamic 
contrast enhanced MRI derived parameters from hotspots. 
A, B. K
trans and microvascular density (Spearman’s correlation = -0.61, p = 0.06) (A), Kep and microvascular density (Spearman’s correlation = 
-0.60, p = 0.07) (B). Dashed line indicates 95% confidence interval. C. Necrotic fraction and K
trans (Spearman’s correlation = -0.34, p = 0.31). 
Solid circle represents group that shows low necrotic fraction and high K
trans. Dashed circle represents group who showed high necrotic fraction 
and low K
trans. MVD = microvascular density, NF = necrotic fraction
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(Fig. 1). According to Spearman’s correlation analysis, 
perfusion parameters from whole transverse ROI did not 
show a significant relationship with MVD, while K
trans and Kep 
from hotspot ROI showed marginally significant correlations 
with MVD (Table 3). Scatter diagrams demonstrated the 
inverse correlation between MVD with K
trans and Kep (r = 
-0.61, p = 0.06 in K
trans; r = -0.60, p = 0.07 in Kep) (Fig. 2). 
The necrotic fraction of the tumor did not show a significant 
relationship with the perfusion parameters regardless of ROI 
(p = 0.27 for K
trans, p = 0.12 for Kep, p = 0.17 for Ve in whole 
transverse section and p = 0.37 for K
trans, p = 0.28 for Kep, p = 
0.68 for Ve in hotspots).
Images of the pixel-by-pixel K
trans analysis of the tumor 
and corresponding immunohistochemical staining of two 
representative mice are shown in Figure 3 and 4. The tumor 
in mouse #2 was one of the smallest with the largest 
diameter being 7.4 mm. Necrosis in the tumor was seldom 
found by histological staining. The K
trans and Kep values 
were highest among the animals measured in the whole 
transverse ROI and also in the hotspot ROI, but their MVD 
values counted the lowest. The tumor from mouse #10 
was the largest one with the largest diameter being 16.4 
mm. The tumor showed massive necrosis at the center and 
cellularity was only preserved in the periphery. The K
trans and 
Kep values were lower than in mouse #2 but the MVD value 
was 2
nd highest among the animals.
DISCUSSION
T1-weighted DCE-MRI may be analyzed semi-
Fig. 3. Pixel-by-pixel analysis of K
trans in tumor of representative mouse #2 evaluated by dynamic contrast enhanced MRI with 
Tofts model.
A. K
trans values of whole tumor (ROI 1) and hotspot (ROI 2) are 0.285/sec and 0.429/sec, respectively. ROI 1 and ROI 2 are marked by red and 
green solid lines. B. Hematoxylin and Eosin staining of corresponding section of mouse #2 (original magnification, x 2). Necrosis is noted in 
center of tumor. C. Hematoxylin and Eosin staining includes hotspot area. Tumor necrosis fraction is 0.03 (original magnification, x 40). Yellow 
line indicates tumor border and red line indicates area of necrosis. D. CD 31 staining of tumor from mouse #2. Microvascular density count is 53 
(original magnification, x 200).
A
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quantitatively (15) or quantitatively (6). For the semi-
quantitative method, the slope of the time-intensity curve 
and the amplitude of the signal intensity are calculated 
directly from the curve. The semi-quantitative method could 
be influenced by scanner settings and might make inter-
patient and inter-system comparisons difficult. Therefore, 
a quantitative analysis has been emphasized and it is 
necessary to explore the meaning of these parameters. 
Previous studies evaluated the relationship between 
semiquantitative values and MVD but there remained some 
controversy regarding the usefulness of semiquantitative 
DCE-MRI parameters in evaluating the angiogenic activity 
of the tumor (8, 11, 12, 16, 17). Studies using quantitative 
DCE-MRI parameters are also still in progress (10, 13, 18).
In this study, quantitative parameters were evaluated 
using the whole transverse section of the tumor slice 
(ROI 1) and the hotspot (ROI 2) to validate the effects 
of ROI selection and to minimize the effects of the 
necrotic area. This rapidly proliferating xenograft tumor 
model underwent necrosis in the central area. It would be 
reasonable to measure hotspots instead of whole tumor 
region when evaluating the status of the tumor using 
DCE-MRI parameters, since no correlation was proven 
between MVD and DCE MR parameters by using whole 
transverse ROI. Averaging the wide necrotic area in the 
tumor area negatively affected the evaluation of DCE-
MRI parameters, regardless of the functional status of 
the tumor. A recent study by Galban et al. (19) stating 
that the parametric response map using the voxel-by-
voxel registered comparison instead of the averaged ROI 
comparison in follow-up studies of brain tumor patients is 
a reliable imaging biomarker for early cancer treatment, and 
Fig. 4. Pixel by pixel analysis of K
trans in tumor of another representative mouse (#10).
A. K
trans values of whole tumors and hotspots were 0.113/sec and 0.237/sec respectively. ROI 1 and ROI 2 are marked by red and green solid 
lines, respectively. B. Hematoxylin and Eosin staining of corresponding section of mouse #10. Large amount of necrosis is shown (original 
magnification, x 2). C. Hematoxylin and Eosin staining including hotspot region. Tumor necrotic fraction is 0.31 (original magnification, x 40). 
Yellow line indicates tumor border and red line indicates area of necrosis. D. CD 31 staining of tissue from mouse #10. Microvascular density 
count is 108 (original magnification, x 200).
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the outcome also supports this study’s results. Similarly, 
Stomper et al. (17) reported that the maximally enhanced 
area showed a broad correlation with MVD.
Although the inverse correlation of K
trans and Kep with 
MVD was not statistically significant, likely due to the small 
sample size, it demonstrated that the feasibility that these 
parameters can be used to evaluate the angiogenic status 
of rapidly proliferating colon cancer. Lastly, K
trans or Kep with 
MVD showed an inverse relationship. Generally, prior studies 
have supported a positive correlation between tissue 
perfusion and MVD (18). Sahani et al. (20) reported that 
the perfusion parameters in the high-grade hepatocellular 
carcinoma group were lower than the well-differentiated 
tumor group which was contrary to conventional belief; 
this observation was attributed to the presence of tumor 
necrosis. In the current study, tumors with large areas of 
necrosis (NF of 0.36 in mouse #5; NF of 0.31 in mouse #10) 
showed lower K
trans (0.299/sec, 0.237/sec respectively), 
while the tumors with small amounts of necrosis (NF of 0.03 
in mouse #2; NF of 0.04 in mouse #9) showed higher K
trans 
(0.429/sec, 0.334/sec respectively). A scatter diagram (Fig. 
2C) depicted the comparison of the two groups. Although 
the relationship between NF and perfusion parameter was 
not statistically significant (p > 0.05), this observation 
led to a reasoning that the degree of tumor necrosis may 
have affected the results. In addition, because MVD could 
not assess the functional status of the capillary wall, a 
high vessel count does not necessarily indicate high tissue 
perfusion. 
Several shortcomings of our study should be noted. 
First, it was difficult to spatially co-localize histology 
with MR images. As a discrepancy was present between 
slice thickness in MRI versus a histological slide section 
(1.04 mm and 6 µm, respectively), a spatial mismatch was 
unavoidable. Also, tumor necrosis was not excluded in the 
whole transverse section (ROI 1). Thus, the quantitative 
parameter from the whole transverse section might not 
reflect the real tumor burden. And the meaning of the 
inverse correlation should be further investigated. Lastly, 
because quantitative parameters showed differences 
according to post-processing methods (21), our results 
should be carefully applied.
In conclusion, quantitative analysis of T1-weighted DCE-
MRI using hotspot ROI may provide a better histologic 
match than using whole transverse section ROI. Within the 
hotspots, K
trans and Kep tended to have a reverse correlation 
with MVD in this colon cancer mouse model. 
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